BRCA2 and cancer: Studies in other DNA repair proteins (e.g., ATM) postulated that missense variants could exert dominant negative effects, however, it was unknown if BRCA2 missense variants previously described could elicit such an effect and increase cancer risk in the heterozygous state or in the ectopic expression state (Tavtigian et al., 2009).